BIOXCEL THERAPEUTICS INC (BTAI) Stock Institutional Owners
BIOXCEL THERAPEUTICS INC (BTAI) is held by 1 institutional investors with a total value of $385,902. This comprehensive analysis highlights the top institutional holders led by Oaktree Capital Management, and others, who collectively account for nearly 100% of the total institutional ownership.Oaktree Capital Management remains the largest institutional holder with a position worth $385,902. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.
Explore more:
- BIOXCEL THERAPEUTICS INC (BTAI) stock institutional trading activity
- BIOXCEL THERAPEUTICS INC (BTAI) stock insider trading activity
- Stock rankings
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance |
|---|---|---|---|---|
| Oaktree Capital Management | Howard Marks | 0.01% | 241,188 | $385,902 |
Frequently asked questions about BTAI
Who owns the most BTAI stock?
The largest holders of BTAI are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BIOXCEL THERAPEUTICS INC (BTAI).
Is BTAI widely held by superinvestors?
Many widely followed stocks like BTAI appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BTAI is represented among the institutional managers we track.